Literature DB >> 32363117

Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion.

Mumtaz Y Balkhi1,2,3.   

Abstract

Exhaustion cripples T cell effector responses against metastatic cancers and chronic infections alike. There has been considerable interest in understanding the molecular and cellular mechanisms driving T cell exhaustion in human cancers fueled by the success of immunotherapy drugs especially the checkpoint receptor blockade (CRB) inhibitory antibodies that reverses T cell functional exhaustion. The current understanding of molecular mechanism of T cell exhaustion has been elucidated from the studies utilizing murine models of chronic viral infections. These studies have formed the basis for much of our understanding of the process of exhaustion and proven vital to developing anti-exhaustion therapies against human cancers. In this review, we discuss the T cell exhaustion differentiation pathway in cancers and chronic viral infections and explore how the transcription factors expression dynamics play role in T cell exhaustion fate choices and maturation. Finally, we summarize the role of some of the most important transcription factors involved in T cell functional exhaustion and construct exhaustion specific signaling pathway maps.
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Entities:  

Keywords:  CD8 T cells; cancer; checkpoint receptors; chronic viral infections; two axes of exhaustion

Mesh:

Substances:

Year:  2020        PMID: 32363117      PMCID: PMC7185212          DOI: 10.1080/2162402X.2020.1747349

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  179 in total

1.  Preferential localization of effector memory cells in nonlymphoid tissue.

Authors:  D Masopust; V Vezys; A L Marzo; L Lefrançois
Journal:  Science       Date:  2001-03-01       Impact factor: 47.728

2.  Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.

Authors:  Sanja Stevanović; Anna Pasetto; Sarah R Helman; Jared J Gartner; Todd D Prickett; Bryan Howie; Harlan S Robins; Paul F Robbins; Christopher A Klebanoff; Steven A Rosenberg; Christian S Hinrichs
Journal:  Science       Date:  2017-04-14       Impact factor: 47.728

3.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

5.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

6.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

7.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

8.  Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.

Authors:  Pablo Penaloza-MacMaster; Alice O Kamphorst; Andreas Wieland; Koichi Araki; Smita S Iyer; Erin E West; Leigh O'Mara; Shu Yang; Bogumila T Konieczny; Arlene H Sharpe; Gordon J Freeman; Alexander Y Rudensky; Rafi Ahmed
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

9.  The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage.

Authors:  Qiang Shan; Zhouhao Zeng; Shaojun Xing; Fengyin Li; Stacey M Hartwig; Jodi A Gullicksrud; Samarchith P Kurup; Natalija Van Braeckel-Budimir; Yao Su; Matthew D Martin; Steven M Varga; Ichiro Taniuchi; John T Harty; Weiqun Peng; Vladimir P Badovinac; Hai-Hui Xue
Journal:  Nat Immunol       Date:  2017-06-12       Impact factor: 25.606

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more
  2 in total

Review 1.  Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment.

Authors:  Weinan Wang; Rui Zou; Ye Qiu; Jishuang Liu; Yu Xin; Tianzhu He; Zhidong Qiu
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 2.  Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development.

Authors:  Natalya Lisovska
Journal:  Oncol Lett       Date:  2022-04-29       Impact factor: 3.111

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.